These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

418 related articles for article (PubMed ID: 34031601)

  • 1. Partial recovery of visual function in a blind patient after optogenetic therapy.
    Sahel JA; Boulanger-Scemama E; Pagot C; Arleo A; Galluppi F; Martel JN; Esposti SD; Delaux A; de Saint Aubert JB; de Montleau C; Gutman E; Audo I; Duebel J; Picaud S; Dalkara D; Blouin L; Taiel M; Roska B
    Nat Med; 2021 Jul; 27(7):1223-1229. PubMed ID: 34031601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retinitis pigmentosa: eye sight restoration by optogenetic therapy].
    Roska B; Busskamp V; Sahel JA; Picaud S
    Biol Aujourdhui; 2013; 207(2):109-21. PubMed ID: 24103341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selecting Channelrhodopsin Constructs for Optimal Visual Restoration in Differing Light Conditions.
    Ganjawala TH; Pan ZH
    Methods Mol Biol; 2021; 2191():189-199. PubMed ID: 32865746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optogenetic restoration of retinal ganglion cell activity in the living primate.
    McGregor JE; Godat T; Dhakal KR; Parkins K; Strazzeri JM; Bateman BA; Fischer WS; Williams DR; Merigan WH
    Nat Commun; 2020 Apr; 11(1):1703. PubMed ID: 32245977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A New Promoter Allows Optogenetic Vision Restoration with Enhanced Sensitivity in Macaque Retina.
    Chaffiol A; Caplette R; Jaillard C; Brazhnikova E; Desrosiers M; Dubus E; Duhamel L; Macé E; Marre O; Benoit P; Hantraye P; Bemelmans AP; Bamberg E; Duebel J; Sahel JA; Picaud S; Dalkara D
    Mol Ther; 2017 Nov; 25(11):2546-2560. PubMed ID: 28807567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvaging ruins: reverting blind retinas into functional visual sensors.
    Mutter M; Swietek N; Münch TA
    Methods Mol Biol; 2014; 1148():149-60. PubMed ID: 24718800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional Availability of ON-Bipolar Cells in the Degenerated Retina: Timing and Longevity of an Optogenetic Gene Therapy.
    Kralik J; Kleinlogel S
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Restoring visual function to blind mice with a photoswitch that exploits electrophysiological remodeling of retinal ganglion cells.
    Tochitsky I; Polosukhina A; Degtyar VE; Gallerani N; Smith CM; Friedman A; Van Gelder RN; Trauner D; Kaufer D; Kramer RH
    Neuron; 2014 Feb; 81(4):800-13. PubMed ID: 24559673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved CoChR Variants Restore Visual Acuity and Contrast Sensitivity in a Mouse Model of Blindness under Ambient Light Conditions.
    Ganjawala TH; Lu Q; Fenner MD; Abrams GW; Pan ZH
    Mol Ther; 2019 Jun; 27(6):1195-1205. PubMed ID: 31010741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards optogenetic vision restoration with high resolution.
    Ferrari U; Deny S; Sengupta A; Caplette R; Trapani F; Sahel JA; Dalkara D; Picaud S; Duebel J; Marre O
    PLoS Comput Biol; 2020 Jul; 16(7):e1007857. PubMed ID: 32667921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting channelrhodopsin-2 to ON-bipolar cells with vitreally administered AAV Restores ON and OFF visual responses in blind mice.
    Macé E; Caplette R; Marre O; Sengupta A; Chaffiol A; Barbe P; Desrosiers M; Bamberg E; Sahel JA; Picaud S; Duebel J; Dalkara D
    Mol Ther; 2015 Jan; 23(1):7-16. PubMed ID: 25095892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and durability of effect of contralateral-eye administration of AAV2 gene therapy in patients with childhood-onset blindness caused by RPE65 mutations: a follow-on phase 1 trial.
    Bennett J; Wellman J; Marshall KA; McCague S; Ashtari M; DiStefano-Pappas J; Elci OU; Chung DC; Sun J; Wright JF; Cross DR; Aravand P; Cyckowski LL; Bennicelli JL; Mingozzi F; Auricchio A; Pierce EA; Ruggiero J; Leroy BP; Simonelli F; High KA; Maguire AM
    Lancet; 2016 Aug; 388(10045):661-72. PubMed ID: 27375040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optogenetic Vision Restoration Using Rhodopsin for Enhanced Sensitivity.
    Gaub BM; Berry MH; Holt AE; Isacoff EY; Flannery JG
    Mol Ther; 2015 Oct; 23(10):1562-71. PubMed ID: 26137852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phototoxicities Caused by Continuous Light Exposure Were Not Induced in Retinal Ganglion Cells Transduced by an Optogenetic Gene.
    Tabata K; Sugano E; Hatakeyama A; Watanabe Y; Suzuki T; Ozaki T; Fukuda T; Tomita H
    Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Canine and human visual cortex intact and responsive despite early retinal blindness from RPE65 mutation.
    Aguirre GK; Komáromy AM; Cideciyan AV; Brainard DH; Aleman TS; Roman AJ; Avants BB; Gee JC; Korczykowski M; Hauswirth WW; Acland GM; Aguirre GD; Jacobson SG
    PLoS Med; 2007 Jun; 4(6):e230. PubMed ID: 17594175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic reactivation of cone photoreceptors restores visual responses in retinitis pigmentosa.
    Busskamp V; Duebel J; Balya D; Fradot M; Viney TJ; Siegert S; Groner AC; Cabuy E; Forster V; Seeliger M; Biel M; Humphries P; Paques M; Mohand-Said S; Trono D; Deisseroth K; Sahel JA; Picaud S; Roska B
    Science; 2010 Jul; 329(5990):413-7. PubMed ID: 20576849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of Vision and Retinal Responses After Adeno-Associated Virus-Mediated Optogenetic Therapy in Blind Dogs.
    Nikonov S; Aravand P; Lyubarsky A; Nikonov R; Luo AJ; Wei Z; Maguire AM; Phelps NT; Shpylchak I; Willett K; Aleman TS; Huckfeldt RM; Ramachandran PS; Bennett J
    Transl Vis Sci Technol; 2022 May; 11(5):24. PubMed ID: 35604672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optogenetic approaches to therapy for inherited retinal degenerations.
    De Silva SR; Moore AT
    J Physiol; 2022 Nov; 600(21):4623-4632. PubMed ID: 35908243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying photoreceptors in blind eyes caused by RPE65 mutations: Prerequisite for human gene therapy success.
    Jacobson SG; Aleman TS; Cideciyan AV; Sumaroka A; Schwartz SB; Windsor EA; Traboulsi EI; Heon E; Pittler SJ; Milam AH; Maguire AM; Palczewski K; Stone EM; Bennett J
    Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6177-82. PubMed ID: 15837919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optogenetic therapy: high spatiotemporal resolution and pattern discrimination compatible with vision restoration in non-human primates.
    Gauvain G; Akolkar H; Chaffiol A; Arcizet F; Khoei MA; Desrosiers M; Jaillard C; Caplette R; Marre O; Bertin S; Fovet CM; Demilly J; Forster V; Brazhnikova E; Hantraye P; Pouget P; Douar A; Pruneau D; Chavas J; Sahel JA; Dalkara D; Duebel J; Benosman R; Picaud S
    Commun Biol; 2021 Jan; 4(1):125. PubMed ID: 33504896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.